DE3579110D1 - Senfgas-derivate der c-6-aminogalaktose und ihre verwendung. - Google Patents

Senfgas-derivate der c-6-aminogalaktose und ihre verwendung.

Info

Publication number
DE3579110D1
DE3579110D1 DE8585307874T DE3579110T DE3579110D1 DE 3579110 D1 DE3579110 D1 DE 3579110D1 DE 8585307874 T DE8585307874 T DE 8585307874T DE 3579110 T DE3579110 T DE 3579110T DE 3579110 D1 DE3579110 D1 DE 3579110D1
Authority
DE
Germany
Prior art keywords
sub
group
aminogalactos
proviso
sulfonate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8585307874T
Other languages
English (en)
Inventor
Eugene Mcpherson
Philip S Schein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Original Assignee
Georgetown University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georgetown University filed Critical Georgetown University
Application granted granted Critical
Publication of DE3579110D1 publication Critical patent/DE3579110D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/12—Acyclic radicals, not substituted by cyclic structures attached to a nitrogen atom of the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)
DE8585307874T 1984-10-31 1985-10-30 Senfgas-derivate der c-6-aminogalaktose und ihre verwendung. Expired - Fee Related DE3579110D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/666,904 US4656159A (en) 1984-10-31 1984-10-31 Galactose-C-6 nitrogen mustard compounds and their uses

Publications (1)

Publication Number Publication Date
DE3579110D1 true DE3579110D1 (de) 1990-09-13

Family

ID=24675999

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8585307874T Expired - Fee Related DE3579110D1 (de) 1984-10-31 1985-10-30 Senfgas-derivate der c-6-aminogalaktose und ihre verwendung.

Country Status (5)

Country Link
US (1) US4656159A (de)
EP (1) EP0181154B1 (de)
JP (1) JPS61118394A (de)
AT (1) ATE55390T1 (de)
DE (1) DE3579110D1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0249008B1 (de) * 1986-05-09 1993-09-15 Pulverer, Gerhard, Prof. Dr.Dr.h.c. Verwendung von spezifischen Monosacchariden zur Herstellung eines Arzneimittels zur Verhinderung von Metastasen maligner Tumore
US5126438A (en) * 1990-12-07 1992-06-30 Hawaiian Sugar Planters' Association 6,6'-dihalo-6,6'-dideoxy-1',2,3,3',4,4'-hexa-o-methylsucrose compounds
US6075134A (en) * 1997-05-15 2000-06-13 The Regents Of The University Of California Glycoconjugates and methods
CN1264616C (zh) * 2001-09-07 2006-07-19 株式会社神户制钢所 废弃化学武器中固体残渣的中和处理方法
US20050220862A1 (en) * 2004-03-31 2005-10-06 Bernstein Joel E Compositions with reduced hepatotoxicity
WO2009006613A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
WO2009006591A1 (en) * 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Inhibitors of polysialic acid de-n-acetylase and methods for using the same
CA2690440A1 (en) 2007-07-03 2009-01-08 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
US8193182B2 (en) 2008-01-04 2012-06-05 Intellikine, Inc. Substituted isoquinolin-1(2H)-ones, and methods of use thereof
SG187425A1 (en) 2008-01-04 2013-02-28 Intellikine Llc Certain chemical entities, compositions and methods
US8703778B2 (en) 2008-09-26 2014-04-22 Intellikine Llc Heterocyclic kinase inhibitors
WO2010129816A2 (en) 2009-05-07 2010-11-11 Intellikine, Inc. Heterocyclic compounds and uses thereof
CA2799579A1 (en) 2010-05-21 2011-11-24 Intellikine, Inc. Chemical compounds, compositions and methods for kinase modulation
CN103298474B (zh) 2010-11-10 2016-06-29 无限药品股份有限公司 杂环化合物及其用途
ES2637113T3 (es) 2011-01-10 2017-10-10 Infinity Pharmaceuticals, Inc. Procedimientos para preparar isoquinolinonas y formas sólidas de isoquinolinonas
CA2842190A1 (en) 2011-07-19 2013-01-24 Infinity Pharmaceuticals Inc. Heterocyclic compounds and uses thereof
US8969363B2 (en) 2011-07-19 2015-03-03 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
RU2014111823A (ru) 2011-08-29 2015-10-10 Инфинити Фармасьютикалз, Инк. Гетероциклические соединения и их применения
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
US8828998B2 (en) 2012-06-25 2014-09-09 Infinity Pharmaceuticals, Inc. Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using PI3 kinase inhibitors
US9481667B2 (en) 2013-03-15 2016-11-01 Infinity Pharmaceuticals, Inc. Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
MX2021012208A (es) 2013-10-04 2023-01-19 Infinity Pharmaceuticals Inc Compuestos heterocíclicos y usos de los mismos.
US9751888B2 (en) 2013-10-04 2017-09-05 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
MX2016012021A (es) 2014-03-19 2017-04-13 Infinity Pharmaceuticals Inc Compuestos heterociclicos para utilizarlos en el tratamiento de trastornos mediados por pi3k-gamma.
US20150320755A1 (en) 2014-04-16 2015-11-12 Infinity Pharmaceuticals, Inc. Combination therapies
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP3350183A1 (de) 2015-09-14 2018-07-25 Infinity Pharmaceuticals, Inc. Feste formen von isochinolinonderivaten, herstellungsverfahren, zusammensetzungen damit und verwendungsverfahren dafür
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
AU2017281797A1 (en) 2016-06-24 2019-01-24 Infinity Pharmaceuticals, Inc. Combination therapies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA747912A (en) * 1966-12-06 W. Hanske Willi Process for the production of deoxyribonuclease blocking agents and products obtained thereby
US2715123A (en) * 1951-11-15 1955-08-09 John E Hodge Method for conducting the amadori rearrangement of n-glycosides
NL237073A (de) * 1958-03-14
JPS42400Y1 (de) * 1964-04-18 1967-01-11

Also Published As

Publication number Publication date
US4656159A (en) 1987-04-07
ATE55390T1 (de) 1990-08-15
JPH0216757B2 (de) 1990-04-18
JPS61118394A (ja) 1986-06-05
EP0181154B1 (de) 1990-08-08
EP0181154A3 (en) 1988-01-27
EP0181154A2 (de) 1986-05-14

Similar Documents

Publication Publication Date Title
DE3579110D1 (de) Senfgas-derivate der c-6-aminogalaktose und ihre verwendung.
ES8206488A1 (es) Un procedimiento para preparar compuestos de purina y piri- midina
CA2079413A1 (en) Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use
FI971935A (fi) Polyanioniset bentsyyliglykosidit sileän lihaskudoksen solujen lisääntymisen estäjinä
ES8706163A1 (es) Procedimiento para la fabricacion de nuevos derivados nu- cleosidos
NZ213550A (en) Purine-substituted nucleoside derivatives and pharmaceutical compositions
NO855241L (no) Fremgangsmaate til fremstilling av karbapenemforbindelser.
ES8705425A1 (es) Un compuesto.
GR852813B (de)
IE811037L (en) Taurine derivatives
IL74401A0 (en) Thiophenylureas,their production and use
AU5154985A (en) Fluoro coumarins and derivatives thereof as antilymphoedema agents
IE862062L (en) Androst-5-en-17-ones
ES8705421A1 (es) Un procedimiento para la preparacion de 4-amino-2-fenil-quinolinas
ES8800910A1 (es) Un procedimiento para la preparacion de nuevas quinazolindionas
NZ217593A (en) 7-aminoazolo(1,5-a pyrimidine derivatives and fungicidal compositions
ES542126A0 (es) Un procedimiento para preparar un derivado de 1,5 beurotiarepina.
EP0118564A4 (de) 4-amino-tetrahydro-2-naphthoesäureabkömmlinge.
ES8607313A1 (es) Un metodo de preparar espiro-(benzofuran-azalcanos)
ES550059A0 (es) Un procedimiento para la preparacion de nuevos derivados de aminobenzamida.
EP0151094A3 (de) Pharmakologisch aktive Imidazopyridinverbindungen
ES8601931A1 (es) Procedimiento para preparar imidazoles y triazoles con es- tructura de enoleter
IE841441L (en) 1-phenoxy-3-hydroxyindolyl-alkylamino-3-propanols.
Lin et al. 4, 4, 5, 5-Tetradehydro-11-deoxy-PGE 1 analogs
ES8504781A1 (es) Procedimiento de preparacion de nuevos uracilos sustituidos en 1 por un grupo feniloxicarbonilo sustituido.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee